SpotLight-19™: Advanced Pathogen Detection and Management
SpotLight-19™ was designed by our team to fulfill the critical need for fast, dependable, and affordable asymptomatic screening during the COVID-19 pandemic. This innovative solution ensures rapid detection, allowing for timely interventions to prevent the spread of infectious diseases.
We continuously refine our technology platform to stay ahead of the curve, ensuring our screening methods effectively combat emerging pathogens. With SpotLight-19™, we’re prepared for today’s demands and the future’s uncertainties.
Importance of Detecting Asymptomatic Infection
Asymptomatic testing is essential in managing a viral pathogen pandemic. It enables the identification of individuals who, despite not exhibiting symptoms, can still transmit the virus. By detecting and isolating these carriers, we can effectively prevent silent transmission, safeguard vulnerable populations, and enhance outbreak control measures.
Future-Proof Technology for Emerging Threats
Chemical reagent tests are typically developed for a specific pathogen, they come with an expiration date. After this date, the tests must be destroyed, leading to significant waste and disposal challenges. The disposal of expired chemical reagents involves strict protocols to ensure safety and environmental compliance, which can be both costly and logistically complex. This process not only generates hazardous waste but also results in financial losses due to the destruction of unused tests.
SpotLight-19™ eliminates the need for destroying tests and the disposal of chemical reagents. Unlike traditional chemical reagent tests, SpotLight-19™ uses advanced, non-invasive technology that does not rely on perishable chemical components. This means there is no expiration date, and the technology can be continuously updated to detect new pathogens without the need for new reagents. This approach significantly reduces environmental impact and minimizes logistical challenges associated with test distribution and inventory management. By eliminating the production of hazardous chemical waste, SpotLight-19™ offers a more sustainable and cost-effective solution for global viral screening.
Why SpotLight-19™?
It takes rapid antigen tests three consecutive days of testing to achieve the asymptomatic sensitivity that SpotLight-19™ achieves within 30 seconds. This breakthrough not only saves valuable time but also offers unparalleled convenience and asymptomatic accuracy, particularly in large population, high throughput environments.
